07.26.13
Abbott Laboratories has gained U.S. Food and Drug Administration 510(k) clearance for its Freestyle Precision Pro Blood Glucose and β-Ketone (Beta ketone) Monitoring System. The system is a blood glucose monitoring system designed to help in the reduction of the risk of test strip cross-contamination.
“The Freestyle Precision Pro system represents a significant step forward as we work to provide tools to improve the way hospitals manage patients’ glucose levels,” said Heather L. Mason, senior vice president of diabetes care at Abbott. “It makes the data available in real time, thanks to the meter’s new wireless capabilities. With its individually foil-wrapped test strips, the system is also designed to help reduce test strip cross-contamination in hospital environments.”
The Freestyle system uses individually foil-wrapped test strips, intended to help reduce the risk of test strip cross-contamination of blood and bacteria; it has a replaceable strip port that can be removed for replacement on-site. The device is designed to communicate wirelessly between the handheld meter at the patient bedside and the hospital information system, which is hoped to give clinical staff immediate access to patient results throughout their facility. The new system adds technology to read newer 2-D barcodes, which are becoming more prevalent in healthcare identification systems. Barcodes in the healthcare system are often used to represent data.
Abbott Diabetes Care, based in Alameda, Calif., makes glucose monitoring systems. Parent company Abbott Laboratories is based in Abbott Park, Ill., just outside Chicago.
“The Freestyle Precision Pro system represents a significant step forward as we work to provide tools to improve the way hospitals manage patients’ glucose levels,” said Heather L. Mason, senior vice president of diabetes care at Abbott. “It makes the data available in real time, thanks to the meter’s new wireless capabilities. With its individually foil-wrapped test strips, the system is also designed to help reduce test strip cross-contamination in hospital environments.”
The Freestyle system uses individually foil-wrapped test strips, intended to help reduce the risk of test strip cross-contamination of blood and bacteria; it has a replaceable strip port that can be removed for replacement on-site. The device is designed to communicate wirelessly between the handheld meter at the patient bedside and the hospital information system, which is hoped to give clinical staff immediate access to patient results throughout their facility. The new system adds technology to read newer 2-D barcodes, which are becoming more prevalent in healthcare identification systems. Barcodes in the healthcare system are often used to represent data.
Abbott Diabetes Care, based in Alameda, Calif., makes glucose monitoring systems. Parent company Abbott Laboratories is based in Abbott Park, Ill., just outside Chicago.